Skip to content

Application of integrated traditional Chinese and Western medicine care in senile dementia patients

Application of integrated traditional Chinese and Western medicine care in senile dementia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005557
Enrollment
Unknown
Registered
2022-01-24
Start date
2021-03-25
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

two:huanglian wendan decoction
three:aromatherapy
fou:blank control

Sponsors

Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The diagnostic criteria of AD from the National Institute of Neurology, Speech and Stroke and the Association for AD and Related Disorders (NINCDS--ADRDA) were adopted: (1) The presence of dementia was confirmed by survey scale and neuropsychological examination; (2) =2 cognitive impairment; (3) Progressive deterioration of memory and other cognitive functions; (4) Unconscious disorder; (5) Absence of systemic diseases or other encephalopathies that could explain memory and cognitive deficits. (6) Clinical Dementia Rating Scale (CDR) =1.0 points. Support the standard (1) Progressive impairment of specific cognitive functions such as speech (aphasia), motor skills (apraxia) and perception (agnosia). (2) Impairment of daily living functions or changes in behavior patterns. (3) There is a family history of similar diseases, especially with neuropathological or laboratory evidence. (4) The laboratory checked that the lumbar puncture pressure was normal;Normal or no special changes in eeg such as slow wave increase;Brain atrophy was confirmed by CT or MRI with progressive aggravation on follow-up examination.

Exclusion criteria

Exclusion criteria: (1) Patients with serious primary diseases whose conditions are complex and unpredictable; (2) Patients with conscious disorder or mental illness who cannot cooperate with the examination, or with hearing impairment, visual impairment, aphasia, agnosia and other severe neurological defects that affect the functional evaluation; (3) patients with severe dyspepsia, or gastrointestinal obstruction, or gastric and duodenal ulcers, and other gastrointestinal diseases that affect drug absorption; (4) patients allergic to the drugs in the study; (5) Patients with external treatment (such as acupuncture, physiotherapy, etc.).

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index,PQSI;TCM symptom quantification score table;MMSE;Quality of Life-Alzheimer's Disease,QOL-AD;

Secondary

MeasureTime frame
SF-36;The Neuropsychiatric Inventory-Questionnaire,NPI-Q;LMS;ADL;

Countries

China

Contacts

Public ContactLinLin
617866353@qq.com13688119536

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026